Pan‐cancer analysis demonstrated that CD2BP2‐DT was highly expressed in breast cancer, bladder urothelial carcinoma, and several other solid tumors compared to their corresponding normal tissues (Figure 1C). The gene discussed is CD2BP2; the disease is bladder transitional cell carcinoma.